- cafead Aug 13, 2024 at 11:22: PM
via A deal to bring back former CEO Robert Foster, Ph.D., didn’t completely quell investors’ concerns about Aurinia Pharmaceuticals.
An activist investor who owns 2.2% of Aurinia’s shares is calling for board and leadership changes at the Canadian biotech.
article source
An activist investor who owns 2.2% of Aurinia’s shares is calling for board and leadership changes at the Canadian biotech.
article source